BG60501B1 - Холестираминова таблетка и метод за получаванетой - Google Patents

Холестираминова таблетка и метод за получаванетой Download PDF

Info

Publication number
BG60501B1
BG60501B1 BG91463A BG9146390A BG60501B1 BG 60501 B1 BG60501 B1 BG 60501B1 BG 91463 A BG91463 A BG 91463A BG 9146390 A BG9146390 A BG 9146390A BG 60501 B1 BG60501 B1 BG 60501B1
Authority
BG
Bulgaria
Prior art keywords
cholestyramine
agglomerates
tablet
weight
moisture content
Prior art date
Application number
BG91463A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG91463A (bg
Inventor
Robert Bequette
Bruce Bonenberger
Claude Gallian
John Reckelhoff
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of BG91463A publication Critical patent/BG91463A/bg
Publication of BG60501B1 publication Critical patent/BG60501B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BG91463A 1989-03-16 1990-03-14 Холестираминова таблетка и метод за получаванетой BG60501B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,167 US4956182A (en) 1989-03-16 1989-03-16 Direct compression cholestyramine tablet and solvent-free coating therefor

Publications (2)

Publication Number Publication Date
BG91463A BG91463A (bg) 1993-12-24
BG60501B1 true BG60501B1 (bg) 1995-06-30

Family

ID=23262387

Family Applications (1)

Application Number Title Priority Date Filing Date
BG91463A BG60501B1 (bg) 1989-03-16 1990-03-14 Холестираминова таблетка и метод за получаванетой

Country Status (34)

Country Link
US (1) US4956182A (cs)
EP (1) EP0387885B1 (cs)
JP (1) JP2974719B2 (cs)
KR (1) KR0140211B1 (cs)
CN (1) CN1047935C (cs)
AR (1) AR246012A1 (cs)
AT (1) ATE128031T1 (cs)
AU (1) AU617601B2 (cs)
BG (1) BG60501B1 (cs)
CA (1) CA2012300A1 (cs)
CS (1) CS277488B6 (cs)
CY (1) CY1899A (cs)
DD (1) DD292837A5 (cs)
DE (1) DE69022452T2 (cs)
DK (1) DK0387885T3 (cs)
EG (1) EG19669A (cs)
ES (1) ES2078917T3 (cs)
FI (1) FI92464C (cs)
GR (1) GR3017460T3 (cs)
HK (1) HK51396A (cs)
HU (1) HU209958B (cs)
IE (1) IE70591B1 (cs)
IL (1) IL93720A0 (cs)
MY (1) MY109744A (cs)
NO (1) NO176043C (cs)
NZ (1) NZ232864A (cs)
OA (1) OA09198A (cs)
PL (1) PL163301B1 (cs)
PT (1) PT93452B (cs)
RO (1) RO106953B1 (cs)
RU (1) RU2069558C1 (cs)
YU (1) YU52390A (cs)
ZA (1) ZA902001B (cs)
ZW (1) ZW1890A1 (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
JP4334616B2 (ja) * 1994-09-22 2009-09-30 ナームローゼ・フエンノートチヤツプ・オルガノン 湿式粒状化による投与単位体を製造する方法
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
EP1126826B3 (en) 1998-11-02 2019-05-15 Alkermes Pharma Ireland Limited Multiparticulate modified release composition of methylphenidate
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
IL157075A0 (en) * 2001-02-13 2004-02-08 Astrazeneca Ab Novel modified release formulation
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
CA2461616A1 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
RU2234915C2 (ru) * 2002-06-04 2004-08-27 Дж. Б. Кемикалс энд Фармасьютикалс Лтд. Твердая фармацевтическая композиция для перорального введения и способ ее получения
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
ES2400186T3 (es) * 2004-05-24 2013-04-08 Mepha Schweiz Ag Procedimiento para recubrimiento en seco
ATE415148T1 (de) * 2004-10-19 2008-12-15 Krka Tovarna Zdravil D D Novo Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP3000460A1 (en) 2005-09-15 2016-03-30 Genzyme Corporation Sachet formulation for amine polymers
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
EP2050456A4 (en) * 2006-08-09 2013-01-23 Mitsubishi Tanabe Pharma Corp COMPRESSED
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
ES2699806T3 (es) 2012-04-18 2019-02-12 SpecGx LLC Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata
CN105848894B (zh) 2013-10-25 2018-01-23 株式会社可乐丽 多层薄膜和包含其的夹层玻璃用中间膜
PT3164117T (pt) 2014-07-03 2023-12-12 SpecGx LLC Formulações de libertação imediata de dissuasão de abuso compreendendo polissacáridos não celulósicos
EP3413877B1 (en) * 2016-02-09 2021-04-07 Albireo AB Oral cholestyramine formulation and use thereof
CA3011595C (en) * 2016-02-09 2024-01-02 Albireo Ab Cholestyramine pellets and methods for preparation thereof
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
CY1899A (en) 1990-03-15
JP2974719B2 (ja) 1999-11-10
NO176043C (no) 1995-01-25
HK51396A (en) 1996-03-29
US4956182A (en) 1990-09-11
FI901241A0 (fi) 1990-03-13
PL163301B1 (en) 1994-03-31
IL93720A0 (en) 1990-12-23
NO176043B (no) 1994-10-17
KR900013946A (ko) 1990-10-22
OA09198A (fr) 1992-06-30
CN1045921A (zh) 1990-10-10
ZW1890A1 (en) 1990-10-31
ZA902001B (en) 1990-11-28
EG19669A (en) 1995-08-30
HUT54489A (en) 1991-03-28
KR0140211B1 (ko) 1998-06-01
BG91463A (bg) 1993-12-24
HU901429D0 (en) 1990-06-28
GR3017460T3 (en) 1995-12-31
EP0387885B1 (en) 1995-09-20
CN1047935C (zh) 2000-01-05
YU52390A (en) 1991-10-31
IE70591B1 (en) 1996-12-11
PT93452B (pt) 1996-12-31
DK0387885T3 (da) 1995-11-06
DE69022452T2 (de) 1996-03-14
NO901183L (no) 1990-09-17
MY109744A (en) 1997-05-31
ES2078917T3 (es) 1996-01-01
PT93452A (pt) 1990-11-07
RO106953B1 (ro) 1993-08-30
ATE128031T1 (de) 1995-10-15
AU617601B2 (en) 1991-11-28
EP0387885A2 (en) 1990-09-19
HU209958B (en) 1994-12-28
FI92464B (fi) 1994-08-15
DD292837A5 (de) 1991-08-14
EP0387885A3 (en) 1992-06-17
IE900941L (en) 1990-09-16
AR246012A1 (es) 1994-03-30
CA2012300A1 (en) 1990-09-16
RU2069558C1 (ru) 1996-11-27
FI92464C (fi) 1994-11-25
DE69022452D1 (de) 1995-10-26
JPH03236326A (ja) 1991-10-22
NO901183D0 (no) 1990-03-14
CS277488B6 (en) 1993-03-17
AU5136790A (en) 1990-09-20
NZ232864A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
BG60501B1 (bg) Холестираминова таблетка и метод за получаванетой
US3622677A (en) Compressed tablets containing compacted starch as binder-disintegrant ingredient
US5104648A (en) High ibuprofen content granulations
US4631284A (en) Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
US4904477A (en) Spray dried ibuprofen compositions
EP0456720B1 (en) High ibuprofen content granulations
US5372823A (en) Direct compression cholestyramine tablet and solvent-free coating thereof
AU593452B2 (en) Glass ionomer cement powder
GB2078767A (en) Processed starch process for preparing same and use of same in medicines
JPS6121526B2 (cs)
EP0298666B1 (en) Spray dried ibuprofen compositions
JP4306965B2 (ja) 増量及び分解組成物、その達成方法及びその使用
EP0210661A1 (en) Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
CN116036035A (zh) 一种不含二氧化钛的富马酸伏诺拉生片剂制备方法
CA2312512A1 (en) Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets
US3148123A (en) Granulating and coating tablets
US20010003619A1 (en) Diluent and desintegrating composition, a process for the preparation thereof and the use thereof
CN110051639B (zh) 一种快速崩解型尼麦角林片及其制备方法
JP2006176496A (ja) 固形剤およびその製造方法
CN115812823A (zh) 一种含有丁香挥发油的压片糖果及其制备工艺
JPH0121946B2 (cs)